Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 4Phase NA 1

Status

Terminated 2Recruiting 1Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Pancreatic Neoplasms 1Multiple Myeloma 1Lipodystrophy, Congenital Generalized 1Glioma 1Glioblastoma 1Advanced Fallopian Tube Carcinoma 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Tetanus Toxoid × Clear all
NCT06639074 2025-10-02

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Mayo Clinic

Phase 2 Recruiting
78 enrolled
GynecologicSarcoma

Advanced Fallopian Tube Carcinoma

NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed
175 enrolled 18 charts
CNS

Glioblastoma, Glioma

NCT03848182 2024-04-18

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
10 enrolled 7 charts
Gastrointestinal

Pancreatic Neoplasms, Lipodystrophy, Congenital Generalized

NCT02700841 2024-03-12

Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation

University of Nebraska

Phase 2 Terminated
8 enrolled 8 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡